Cleared Traditional

K855103 - CIRIBART GYUDUBG CATGETER

K855103 is the FDA 510(k) clearance for CIRIBART GYUDUBG CATGETER by Mansfield Scientific, Inc.. It is a Class 2 Cardiovascular device (product code DQO) cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K855103 · Mansfield Scientific, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1986
Decision
57d
Days
Class 2
Risk

K855103 is an FDA 510(k) clearance for the CIRIBART GYUDUBG CATGETER. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Mansfield Scientific, Inc. (Mansfield, US). The FDA issued a Cleared decision on February 18, 1986 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Mansfield Scientific, Inc. devices

Submission Details

510(k) Number K855103 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 1985
Decision Date February 18, 1986
Days to Decision 57 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
68d faster than avg
Panel avg: 125d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 292
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K855103.
ANGIOGRAPHIC CATHETER (CARDIOLOGY & RADIOLOGY)
K861483 · Mallinckrodt Critical Care · May 1986
ACS BRACHIAL CORONARY GUIDING CATH W/TAPERED TIP
K860580 · Advanced Cardiovascular Systems, Inc. · Mar 1986
MODIFIED CORDIS PTCA GUIDING CATHETERS
K854576 · Cordis Corp. · Feb 1986
DIAGNOSTIC INTRAVASCULAR CATHETERS
K853182 · Mallinckrodt Critical Care · Jan 1986
LAP-CATH
K852197 · Research Medical, Inc. · Nov 1985
FAP-CATH
K852456 · Research Medical, Inc. · Nov 1985